Matsumoto Tomo, Hisamatsu Yuji, Ohkusa Tomoko, Inoue Noriko, Sato Takashi, Suzuki Shinsuke, Ikeda Yasuhiro, Matsuzaki Masunori
Division of Cardiovascular Medicine, Department of Medical Bioregulation, Yamaguchi University Graduate, School of Medicine, 1-1-1 Minami-kogushi, Ube Yamaguchi 755-8505, Japan.
Basic Res Cardiol. 2005 May;100(3):250-62. doi: 10.1007/s00395-005-0518-7. Epub 2005 Mar 9.
Sorcin is a 21.6-kDa Ca(2+) binding protein of the penta-EF hand family. Several studies have shown that sorcin modulates multiple proteins involved in excitation-contraction (E-C) coupling in the heart, such as the cardiac ryanodine receptor (RyR2), L-type Ca(2+) channel, and Na(+)-Ca(2+) exchanger, while it has also been shown to be phosphorylated by cAMP-dependent protein kinase (PKA). To elucidate the effects of sorcin and its PKA-dependent regulation on E-C coupling in the heart, we identified the PKA-phosphorylation site of sorcin, and found that serine178 was preferentially phosphorylated by PKA and dephosphorylated by protein phosphatase-1. Isoproterenol allowed sorcin to translocate to the sarcoplasmic reticulum (SR). In addition, adenovirus-mediated overexpression of sorcin in adult rat cardiomyocytes significantly increased both the rate of decay of the Ca(2+) transient and the SR Ca(2+) load. An assay of oxalate-facilitated Ca(2+) uptake showed that recombinant sorcin increased Ca(2+) uptake in a dose-dependent manner. These data suggest that sorcin activates the Ca(2+)-uptake function in the SR. In UM-X7. 1 cardiomyopathic hamster hearts, the relative amount of sorcin was significantly increased in the SR fraction, whereas it was significantly decreased in whole-heart homogenates. In failing hearts, PKA-phosphorylated sorcin was markedly increased, as assessed using a back-phosphorylation assay with immunoprecipitated sorcin. Our results suggest that sorcin activates Ca(2+)-ATPase-mediated Ca(2+) uptake and restores SR Ca(2+) content, and may play critical roles in compensatory mechanisms in both Ca(2+) homeostasis and cardiac dysfunction in failing hearts.
索辛蛋白是一种21.6 kDa的五聚体EF手型家族的钙离子结合蛋白。多项研究表明,索辛蛋白可调节心脏兴奋 - 收缩(E - C)偶联过程中涉及的多种蛋白质,如心肌兰尼碱受体(RyR2)、L型钙离子通道和钠 - 钙交换体,同时也已证实它可被环磷酸腺苷(cAMP)依赖性蛋白激酶(PKA)磷酸化。为了阐明索辛蛋白及其PKA依赖性调节对心脏E - C偶联的影响,我们确定了索辛蛋白的PKA磷酸化位点,发现丝氨酸178优先被PKA磷酸化,并被蛋白磷酸酶 - 1去磷酸化。异丙肾上腺素可使索辛蛋白转位至肌浆网(SR)。此外,腺病毒介导的索辛蛋白在成年大鼠心肌细胞中的过表达显著增加了钙离子瞬变的衰减速率和SR钙离子负荷。草酸盐促进钙离子摄取的测定表明,重组索辛蛋白以剂量依赖性方式增加钙离子摄取。这些数据表明索辛蛋白激活了SR中的钙离子摄取功能。在UM - X7.1心肌病仓鼠心脏中,SR组分中索辛蛋白的相对含量显著增加,而在全心匀浆中则显著降低。在衰竭心脏中,使用免疫沉淀的索辛蛋白进行反向磷酸化测定评估发现,PKA磷酸化的索辛蛋白明显增加。我们的结果表明,索辛蛋白激活钙离子ATP酶介导的钙离子摄取并恢复SR钙离子含量,可能在衰竭心脏的钙离子稳态和心脏功能障碍的代偿机制中发挥关键作用。